{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:12:53Z","timestamp":1790111573985,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T180620"],"award-info":[{"award-number":["2025T180620"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["202421"],"award-info":[{"award-number":["202421"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302765"],"award-info":[{"award-number":["82302765"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.actbio.2026.09.014","type":"journal-article","created":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:44:17Z","timestamp":1788677057000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Local administration of exendin-4 ameliorates wear-particle-induced periprosthetic osteolysis by rebalancing bone remodeling"],"prefix":"10.1016","author":[{"given":"Boyan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6408-8541","authenticated-orcid":false,"given":"Zixiang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6261-8661","authenticated-orcid":false,"given":"Weiping","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2026.09.014_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8122091","article-title":"Periprosthetic osteolysis: mechanisms, prevention and treatment","volume":"8","author":"Goodman","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.actbio.2026.09.014_bib0002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.actbio.2023.02.003","article-title":"Targeted therapy for peri-prosthetic osteolysis using macrophage membrane-encapsulated human urine-derived stem cell extracellular vesicles","volume":"160","author":"Xie","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.09.014_bib0003","doi-asserted-by":"crossref","unstructured":"K.J.B. CF Ibezim, Revision burden: projections in the united states and worldwide, revision total hip arthroplasty (2025).","DOI":"10.1007\/978-3-031-83959-7_1"},{"key":"10.1016\/j.actbio.2026.09.014_bib0004","first-page":"181","article-title":"Macrophage-derived exosomes modulate wear particle-induced osteolysis via miR-3470b targeting TAB3\/NF-\u03baB signaling","volume":"26","author":"Pan","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.actbio.2026.09.014_bib0005","first-page":"171","article-title":"Fused exosomal targeted therapy in periprosthetic osteolysis through regulation of bone metabolic homeostasis","volume":"50","author":"Ma","year":"2025","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.actbio.2026.09.014_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2013.09.034","article-title":"Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-\u03baB as a therapeutic target","volume":"10","author":"Lin","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2026.09.014_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121127","article-title":"Aseptic and septic prosthetic joint loosening: Impact of biomaterial wear on immune cell function, inflammation, and infection","volume":"278","author":"Hodges","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.09.014_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.blo.0000238813.95035.1b","article-title":"The cellular and molecular biology of periprosthetic osteolysis","volume":"454","author":"Purdue","year":"2007","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.actbio.2026.09.014_bib0009","article-title":"Gut-derived peptide hormone analogues and potential treatment of bone disorders in obesity and diabetes mellitus","author":"Ali","year":"2024","journal-title":"Clin. Med. Insights."},{"key":"10.1016\/j.actbio.2026.09.014_bib0010","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41574-024-01000-z","article-title":"Gut hormones and bone homeostasis: potential therapeutic implications","volume":"20","author":"Bouvard","year":"2024","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.actbio.2026.09.014_bib0011","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.actbio.2026.09.014_bib0012","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1210\/en.2007-1292","article-title":"The murine glucagon-like peptide-1 receptor is essential for control of bone resorption","volume":"149","author":"Yamada","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.actbio.2026.09.014_bib0013","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-009-9220-3","article-title":"Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states","volume":"84","author":"Nuche-Berenguer","year":"2009","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.actbio.2026.09.014_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.regpep.2009.06.010","article-title":"Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states","volume":"159","author":"Nuche-Berenguer","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.actbio.2026.09.014_bib0015","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-24-0231","article-title":"The effects of GIP, GLP-1 and GLP-2 on markers of bone turnover: a review of the gut-bone axis","volume":"265","author":"Longo","year":"2025","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.actbio.2026.09.014_bib0016","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41574-024-01066-9","article-title":"Expanding applications of therapies based on GLP1","volume":"21","author":"Drucker","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.actbio.2026.09.014_bib0017","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.actbio.2026.09.014_bib0018","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2026.09.014_bib0019","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-2004-822589","article-title":"[Size and shape of commercially available polyethylene particles for in-vitro and in-vivo-experiments]","volume":"142","author":"von Knoch","year":"2004","journal-title":"Zeitschrift F\u00fcR Orthop\u00e4Die Und Ihre Grenzgebiete"},{"key":"10.1016\/j.actbio.2026.09.014_bib0020","doi-asserted-by":"crossref","first-page":"eadn1852","DOI":"10.1126\/sciadv.adn1852","article-title":"Matrix-bound nanovesicles alleviate particulate-induced periprosthetic osteolysis","volume":"10","author":"Liao","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.actbio.2026.09.014_bib0021","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2474-12-186","article-title":"Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis","volume":"12","author":"Kauther","year":"2011","journal-title":"BMC. Musculoskelet. Disord."},{"key":"10.1016\/j.actbio.2026.09.014_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/jfb14010030","article-title":"Increased UHMWPE particle-induced osteolysis in fetuin-a-deficient mice","volume":"14","author":"Polan","year":"2023","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.actbio.2026.09.014_bib0023","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1016\/j.biomaterials.2007.06.035","article-title":"Wear particles, periprosthetic osteolysis and the immune system","volume":"28","author":"Goodman","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.09.014_bib0024","doi-asserted-by":"crossref","first-page":"28353","DOI":"10.1021\/acsnano.5c06549","article-title":"An immunomodulating regenerating hydrogel that rescues the oxidative microenvironment and reverses cell senescence for osteoporotic bone defects","volume":"19","author":"Wang","year":"2025","journal-title":"ACS. Nano"},{"key":"10.1016\/j.actbio.2026.09.014_bib0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12951-022-01413-w","article-title":"NOX4 blockade suppresses titanium nanoparticle-induced bone destruction via activation of the Nrf2 signaling pathway","volume":"20","author":"Wang","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.actbio.2026.09.014_bib0026","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s12951-024-03049-4","article-title":"Osteoblastic ferroptosis inhibition by small-molecule promoting GPX4 activation for peri-prosthetic osteolysis therapy","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.actbio.2026.09.014_bib0027","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.21006","article-title":"Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob\/ob mice","volume":"43","author":"Ding","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.actbio.2026.09.014_bib0028","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1089\/dia.2011.0050","article-title":"Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes","volume":"13","author":"DeYoung","year":"2011","journal-title":"Diabetes. Technol. Ther."},{"key":"10.1016\/j.actbio.2026.09.014_bib0029","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.biomaterials.2015.08.045","article-title":"Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels","volume":"73","author":"Yue","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2026.09.014_bib0030","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.biomaterials.2013.01.074","article-title":"The future of biologic coatings for orthopaedic implants","volume":"34","author":"Goodman","year":"2013","journal-title":"Biomaterials"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126006033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706126006033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:57:59Z","timestamp":1790110679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706126006033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S1742706126006033"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2026.09.014","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local administration of exendin-4 ameliorates wear-particle-induced periprosthetic osteolysis by rebalancing bone remodeling","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2026.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}